| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |